OPAT is commonly used for a variety of conditions (including endocarditis and bone/joint infections), can lower costs by ...

The incidence of recurrent Clostridioides difficile infection was lower among at-risk patients on antibiotics for other ...

Vancomycin, a glycopeptide antibiotic, is commonly used to treat gram-positive pathogens associated with vascular-access-related infections, such as coagulase negative Staphylococcus species ...

Vancomycin has only rarely been implicated as a cause of thrombocytopenia, and there is only limited evidence that this complication is caused by immune mechanisms. We conducted a study to determin ...

Vancomycin remains one of the most widely used antibiotics for the treatment of Staphylococcus (including methicillin-resistant Staphylococcus aureus), Streptococcus, and Enterococcus infections.

Vancomycin flushing syndrome (VFS) is a reaction to the antibiotic drug vancomycin. Common symptoms consist of a rash that itches during or after the infusion of vancomycin. VFS is the most common ...

Fortunately it is still significantly vulnerable to vancomycin, which has been doctors’ first-line treatment against MRSA infections for 40 years.

Staphylococcus aureus has the potential to develop durable vancomycin resistance, according to a study published August 28, 2024, in the open-access journal PLOS Pathogens by Samuel Blechman and ...

When the density of vancomycin-resistant enterococci in stool was at least 4 log per gram, 10 of 12 sets of cultures of environmental specimens had at least one positive sample, as compared with 1 ...

Recurrent C. diff emerged in 17 of 39 participants receiving vancomycin (43.6%) versus 24 of 42 receiving placebo (57.1%), an absolute difference of −13.5 percentage points (95% CI, −35.1% to ...